Endava is trading at $2.06, up 5.10%, in live trading at 3:01 p.m. EST, with no clear company-specific catalyst identified.
- Needham’s Buy rating was reaffirmed, but reports date it to October 12 and do not link it to the October 13 gain.
- Major U.S. indexes were nearly flat or slightly lower.